Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 27,371 | 19,742 | 11,022 | 8,227 | 6,449 |
| Cost of Goods | 8,760 | 6,217 | 4,276 | 3,448 | 2,635 |
| Gross Profit | 18,611 | 13,525 | 6,746 | 4,779 | 3,814 |
| Operating Expenses | 19,591 | 10,080 | 8,078 | 10,079 | 9,466 |
| Operating Income | -220 | 3,662 | -1,056 | -4,852 | -5,017 |
| Interest Expense | 0 | 5 | 190 | 100 | 0 |
| Other Income | -2,978 | -28,662 | -1,269 | -3,090 | 22 |
| Pre-tax Income | -3,198 | -25,005 | -2,515 | -8,041 | -4,995 |
| Income Tax | -1,541 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -1,657 | -25,005 | -2,515 | -8,041 | -4,995 |
| Minority Interests | N/A | N/A | N/A | -1,166 | -781 |
| Net Income | $-1,657 | $-25,005 | $-2,515 | $-6,875 | $-4,214 |
| EPS Basic Total Ops | -0.09 | -1.56 | -0.21 | -0.54 | -0.35 |
| EPS Basic Continuous Ops | -0.09 | -1.54 | -0.19 | -0.64 | -0.41 |
| EPS Diluted Total Ops | -0.09 | -1.56 | -0.21 | -0.54 | -0.35 |
| EPS Diluted Continuous Ops | -0.09 | -1.54 | -0.19 | -0.64 | -0.41 |
| EPS Diluted Before Non-Recurring Items | 0.08 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,577 | $4,000 | $-620 | $-4,305 | $-4,801 |